Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host

Biochimie

Volumn 92, Issue 6, 2010, Pages 583-587

  Wu, Yongzheng ^a,b   Raymond, Benoît ^a,b   Goossens, Pierre L ^a,c   Njamkepo, Elisabeth ^a,c   Guiso, Nicole ^a,c   Paya, Miguel ^d   Touqui, Lhousseine ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ESTERASE; PHOSPHOLIPASE A2 GROUP IIA; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; BORDETELLA PERTUSSIS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; INNATE IMMUNITY; LUNG INFECTION; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTHRAX; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; ARACHIDONIC ACID; BACILLUS ANTHRACIS; BACTERIAL TOXINS; DRUG RESISTANCE, MICROBIAL; GROUP II PHOSPHOLIPASES A2; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE;

ANIMALIA; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS; ESCHERICHIA COLI; MUS; MUS MUSCULUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 77953287244     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.01.024     Document Type: Review

References (38)

1. WHO Acute Respiratory Infections http://www.who.int/vaccine_research/diseases/ari/en/index.html.
2. Dorman S.E., Chaisson R.E. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat. Med. 2007, 13:295-298.
3. Balough K., McCubbin M., Weinberger M., Smits W., Ahrens R., Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis, Pediatr. Pulmonol. 1995, 20:63-70.
4. Pistelli R., Lange P., Miller D.L. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur. Respir. J. Suppl. 2003, 40:10s-14s.
5. Lehrer R.I. Primate defensins. Nat. Rev. Microbiol. 2004, 2:727-738.
6. Nevalainen T.J., Graham G.G., Scott K.F. Antibacterial actions of secreted phospholipases A2. Review. Biochim. Biophys. Acta 2008, 1781:1-9.
7. Touqui L., Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 2001, 1:739-754.
8. Valentin E., Lambeau G. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim. Biophys. Acta 2000, 1488:59-70.
9. Murakami M., Nakatani Y., Atsumi G., Inoue K., Kudo I. Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 1997, 17:225-283.
10. Nakos G., Kitsiouli E., Hatzidaki E., Koulouras V., Touqui L., Lekka M.E. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome, Crit. Care Med. 2005, 33:772-779.
11. Touqui L., Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol. Med. Today 1999, 5:244-249.
12. Weinrauch Y., Elsbach P., Madsen L.M., Foreman A., Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Invest. 1996, 97:250-257.
13. Koduri R.S., Gronroos J.O., Laine V.J., et al. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 2002, 277:5849-5857.
14. Qu X.D., Lehrer R.I. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 1998, 66:2791-2797.
15. Hunt C.L., Nauseef W.M., Weiss J.P. Effect of D-alanylation of (lipo)teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils. J. Immunol. 2006, 176:4987-4994.
16. Gimenez A.P., Wu Y.Z., Paya M., Delclaux C., Touqui L., Goossens P.L. High bactericidal efficiency of type IIA phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J. Immunol. 2004, 173:521-530.
17. Mock M., Fouet A. Anthrax. Annu. Rev. Microbiol. 2001, 55:647-671.
18. Zwartouw H.T., Smith H. Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity. Biochem. J. 1956, 63:437-442.
19. Weinrauch Y., Abad C., Liang N.S., Lowry S.F., Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J. Clin. Invest. 1998, 102:633-638.
20. Arbibe L., Vial D., Rosinski-Chupin I., et al. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 1997, 159:391-400.
21. Piris-Gimenez A., Paya M., Lambeau G., et al. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J. Immunol. 2005, 175:6786-6791.
22. Laine V.J., Grass D.S., Nevalainen T.J. Protection by group II phospholipase A2 against Staphylococcus aureus. J. Immunol. 1999, 162:7402-7408.
23. Laine V.J., Grass D.S., Nevalainen T.J. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection. Infect. Immun. 2000, 68:87-92.
24. Elsbach P., Weiss J., Levy O. Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 1994, 2:324-328.
25. Dubouix A., Campanac C., Fauvel J., et al. Bactericidal properties of group IIa secreted phospholipase A(2) against Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 2003, 52:1039-1045.
26. Baldari C.T., Tonello F., Paccani S.R., Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 2006, 27:434-440.
27. Raymond B., Ravaux L., Memet S., et al. Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation, Biochem. Pharmacol. 2009.
28. Alaoui-El-Azher M., Wu Y., Havet N., Israel A., Lilienbaum A., Touqui L. Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways. Mol. Pharmacol 2002, 61:786-794.
29. Raymond B., Batsche E., Boutillon F., et al. Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog 2009, 5:e1000359.
30. Menschikowski M., Hagelgans A., Kostka H., Eisenhofer G., Siegert G. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. Neoplasia 2008, 10:1195-1203.
31. Raymond B., Leduc D., Ravaux L., et al. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog. 2007, 3:e187.
32. Vancheri C., Mastruzzo C., Sortino M.A., Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 2004, 25:40-46.
33. Gueirard P., Druilhe A., Pretolani M., Guiso N. Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect. Immun. 1998, 66:1718-1725.
34. Khelef N., Gounon P., Guiso N. Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity. Cell. Microbiol. 2001, 3:721-730.
35. Vojtova J., Kamanova J., Sebo P. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr. Opin. Microbiol. 2006, 9:69-75.
36. Vial D., Senorale-Pose M., Havet N., Molio L., Vargaftig B.B., Touqui L. Expression of the type-II phospholipase A2 in alveolar macrophages. Down-regulation by an inflammatory signal. J. Biol. Chem. 1995, 270:17327-17332.
37. Touqui L., Paya M., Thouron F., et al. Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages. FEBS Lett. 2005, 579:4923-4927.
38. Kitsiouli E., Nakos G., Lekka M.E. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim. Biophys. Acta 2009, 1792:941-953.